The IPOX® Week, July 10, 2017

  • IPOX Indexes start quarter mixed. Corporate actions propel IPOX Global, IPOX International, IPOX Europe and IPOX China.
  • IPOX-linked ETF performance update.
  • Global deal-flow review and outlook: Asia-Pacific is focus as massive number of deals line up.

IPOX Indexes start quarter mixed. Corporate actions propel IPOX Global, IPOX International, IPOX Europe and IPOX China: Amid big corporate action activity benefiting select IPOX Indexes and solid U.S. and European economic data, the IPOX Global (IPGL50) added +0.23% to +14.59% YTD last week, outpacing global equities. Performance within the IPOX Regional Indexes universe was mixed: While weakness in some heavyweights including consumer staple Kraft Heinz (KHC US: -3.04%) continued to pressure the IPOX 100 U.S. (IPXO) Index, select IPOX Indexes continued to be on the winning side of the brisk corporate action activity in the world’s regions, with both the IPOX Europe (IXTE) AND IPOX China (CNI) extending their relative gain vs. the European and Chinese market to +1167 bps. YTD, respectively. IPOX Holdings with big upside included London-based payment processor 10/2015 IPO Worldpay (WPG LN: +17.03%) which surged after agreeing to combine with U.S.-based Vantiv (VNTV US: -3.51%), a former IPOX Indexes portfolio holding. We also note the spectacular gains in IPOX China (IPXUCHHP, CNI) Holding specialty pharma 02/2016 IPO U.S.-traded BeiGene (BGNE US: +55.96%) after New Jersey-based drugmaker USD billion 104 Celgene (CELG US: +4.45%) bought a stake in the company, while social networker Hong-Kong traded 12/2016 IPO Meitu (1357 HK: +29.41%) surged amid massive volume and stake building. Further corporate action activity pertained to China-linked real-estate behemoth China Vanke (2202 HK: +6.56%) which closed in on its all-time high after completing its largest-ever acquisition and a respective private placement in Mainland China.

IPOX-linked ETF Performance update: Last week, the U.S.-focused USD million 838 First Trust U.S. Equity Opportunities ETF (FPX) fell to +10.15% YTD, while the internationally-focused First Trust International IPO ETF (FPXI) rose to +23.68% YTD, benefiting from corporate action activity in some of the aforementioned portfolio holdings.

IPOX Price Returns (%) Last Week Q2 2017 YTD 2017
Exposure: Global/International (xUS) (USD)
IPOX Global (IPGL50) 0.23 5.54 14.59
IPOX Global (IPGL30) -0.57 8.07 15.56
IPOX International (IPXI)* 0.28 9.24 22.13
Exposure: United States (USD)
IPOX Composite U.S. (IPXC)* 0.03 7.44 17.43
IPOX 100 U.S. (IPXO)* -0.37 3.86 9.81
IPOX 30 U.S. (IPXT) -0.14 4.62 10.63
Exposure: Europe/Nordic Region (EUR)
IPOX Europe (IXTE) 0.88 4.95 15.18
IPOX Nordic (IPND) 1.19 8.64 14.16
Exposure: Asia-Pacific/China Region (USD)
IPOX Asia-Pacific (IPTA) -0.90 2.99 10.57
IPOX China C. (IPXUCHCHP)* 0.71 10.06 23.53
IPOX China (CNI) 1.81 4.62 18.79

* Basis for ETPs: FPX US, FPX LN, FPXU FP, FPXI US, TCIP110 IT) and CME Futures (e-mini IPOX 100 U.S. Index Futures [commodity trading symbol: IPOU7]).

Global deal-flow review and outlook: Asia-Pacific is focus as massive number of deals line up: 6 accessible global (non-China A shares) firms debuted during the shortened U.S. trading week with the average (median) equally-weighted stock adding +12.02% (+8.49%) based on the difference between the final offering price and the week’s close. The good initial reception to the week’s largest deals, the IPO of CAD million 652 Toronto-traded Jamieson Wellness Inc. (JWEL CN: +9.84%), as well as Zurich traded CHF million 898 Zur Rose Group AG (ROSE SW: +7.14%) underlines the strong demand for specialty health care. No significant U.S. and European deal flow is seen for the week of July 10, 2017, while a massive number of small- and mid-cap IPOs are set to price and/or commence trading in the Hong Kong market, including Taiwan-based electrical components maker FIT Hong Teng Limited (6088 HK) or paint products maker and distributor CPM Group (1932 HK). Other deals in the region include the re-IPO of Kuala Lumpur-traded plastics maker Lotte Chemical Titan Holdings (TTNP MK), Malaysia’s biggest deal since the IPO of media firm Astro Malaysia Holdings (Astro MK) in October 2012. Amid tepid demand, the firm raised USD million 877 after pricing its IPO at 6.50 ringgit apiece, the bottom of the marketed range.

Traded IPOs (week of July 3, 2017) Country
Jamieson Wellness Inc Canada
Sheng Ye Capital Ltd Hong Kong
Tatton Asset Management PLC Britain
Waberer’s International Zrt Hungary
Xiangxing International Holding Ltd Hong Kong
Zur Rose Group AG Switzerland
Upcoming IPOs (week of July 10, 2017) Country
CPM Group Ltd./HK Hong Kong
Evergreen Products Group Ltd. Hong Kong
FIT Hon Teng Ltd. Hong Kong
Dongguang Chemical Ltd. Hong Kong
Lotte Chemical Titan Holdings Bhd. Malaysia
S&P International Holding Ltd. Hong Kong
UTS Marketing Solutions Ltd. Hong Kong

Josef Schuster is the founder of IPOX Schuster LLC (, a Chicago-based Financial Services company specialized in Financial Products Design related to Initial Public Offerings and corporate Spin-offs. He is the chief architect of the IPOX Indexes, a global index group initiated in 2004 that encompasses an index technology allowing for asset-allocation focused exposure to the “going public” effect associated with global IPOs and Spin-offs. Mr. Schuster earned his Bachelor of Arts degree in Business Administration in 1994 from the European Business School, London. Mr. Schuster was also awarded a MSc in Accounting and Finance in August 1996 and a MPhil / PhD in Accounting and Finance in June 2003 from the London School of Economics.

ABOUT THE IPOX INDEXES: Through the range of the IPOX Indexes, market participants have an innovative opportunity to navigate the global IPO and Spin-off market and to track the performance of this economically significant sector more accurately and comprehensively than with any other index group. The IPOX Indexes accomplish the systematic indexation of the aftermarket performance of the IPO and Spin-off sector, while – at the same time – preserving the benefits of diversification. Linked to the IPOX 100 U.S. Index, for example, IPOX-linked investment products available to investors include the pioneering USD million 600, 5-star First Trust U.S. IPO ETF (ticker: FPX). On February 18, 2016, CME Group, the world’s largest exchange operator, launched e-mini IPOX 100 U.S. Index Futures, offering market participants for the first time a tool to manage the aggregate risk associated with U.S. IPOs and Spin-offs.

Disclosure: the author has no position in the stocks mentioned.

Lightspeed Financial Services Group LLC is not affiliated with these third-party market commentators/educators or service providers. Data, information, and material (“content”) are provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities or contracts. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lightspeed Financial Services Group LLC does not endorse, offer nor recommend any of the services or commentary provided by any of the market commentators/educators or service providers and any information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

The IPOX® Week, October 25th, 2021
Read More
Bank Stocks Kick Of Q3 Earnings Season With A Bang
Read More
The IPOX® Week, October 18th, 2021
Read More
4 Bad Habits That Stock Traders Should Break
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.